Location History:
- Cambridge, MA (US) (2019)
- Lincoln, MA (US) (2020 - 2021)
Company Filing History:
4 out of 3,923 
4 out of 2,595 
Years Active: 2019-2025
Title: The Innovative Mind of Hans Bitter: Pioneering CD Therapies
Introduction
Hans Bitter, an accomplished inventor based in Lincoln, MA, has made significant strides in the field of medical therapies. With a total of three patents to his name, Hans has focused his efforts on developing novel treatments that target specific biomarkers associated with certain diseases, particularly in oncology.
Latest Patents
Hans's latest inventions revolve around groundbreaking therapies involving CD20, CD22, and combination therapies utilizing a CD19 chimeric antigen receptor (CAR). His innovative approach provides compositions and methods for treating diseases associated with the expression of CD19. This includes administering a recombinant T cell comprising the CD19 CAR, alongside various B-cell inhibitors targeting markers such as CD10, CD20, CD22, and others. Additionally, his patents disclose novel antigen-binding domains and CAR molecules directed toward CD20 and CD22, with potential applications in both monotherapy and combination therapy contexts. The inventions also encompass kits and therapeutic compositions, aiming to improve treatment outcomes for patients.
Career Highlights
Throughout his career, Hans Bitter has significantly impacted the medical research field. He has been affiliated with prestigious organizations, including Novartis AG and the University of Pennsylvania. His work in these institutions has allowed him to integrate industry knowledge with academic research, fostering innovation in therapeutic development.
Collaborations
Hans has collaborated with several respected professionals in his field, including Jennifer Brogdon and Elena Orlando. These partnerships have been essential in enhancing the scope and effectiveness of his research initiatives, driving forward the development of new therapies aimed at combating serious health conditions.
Conclusion
In summary, Hans Bitter stands out as a visionary inventor in the realm of therapeutic innovations. His dedication to advancing medical science through targeted therapies is reflected in his patents and collaborations. With a continued focus on CD-based treatments, Hans is likely to contribute even more to the field of medicine in the years to come.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.